ciprofloxacin has been researched along with Infections, Vibrio in 20 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "vulnificus septicemia during the study, and the 30-day survival rate was 39% (85/218)." | 1.51 | Outcomes of Third-Generation Cephalosporin Plus Ciprofloxacin or Doxycycline Therapy in Patients with Vibrio vulnificus Septicemia: A Propensity Score-Matched Analysis. ( Darboe, KS; Jang, HC; Jung, SI; Kang, SJ; Kim, SE; Kim, UJ; Oh, TH; Park, KH; Shin, HY; Shin, SU, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 12 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, CY | 1 |
| Huang, YT | 1 |
| Liao, CH | 1 |
| Hsueh, PR | 1 |
| Usta, J | 1 |
| Araj, G | 1 |
| Taleb, R | 1 |
| Majere, RA | 1 |
| Cortina, S | 1 |
| Trinh, SA | 1 |
| Gavin, HE | 1 |
| Satchell, KJF | 1 |
| Kim, SE | 3 |
| Shin, SU | 1 |
| Oh, TH | 1 |
| Kim, UJ | 2 |
| Darboe, KS | 2 |
| Kang, SJ | 3 |
| Jang, HC | 3 |
| Jung, SI | 3 |
| Shin, HY | 1 |
| Park, KH | 3 |
| Kim, HK | 2 |
| Choi, SM | 2 |
| Yu, Y | 1 |
| Kang, G | 1 |
| Kim, YR | 2 |
| Rhee, JH | 2 |
| Ryu, PY | 1 |
| Lee, TH | 1 |
| Choy, HE | 1 |
| Han, H | 1 |
| Li, F | 1 |
| Xu, J | 1 |
| Chen, Y | 1 |
| Yu, D | 1 |
| Yan, S | 1 |
| Wu, Q | 1 |
| Li, W | 1 |
| Guo, Y | 1 |
| Li, N | 1 |
| Hsieh, TC | 1 |
| Jean, SS | 1 |
| Ou, TY | 1 |
| Chen, FL | 1 |
| Lee, WS | 1 |
| Nazir, S | 1 |
| Brown, K | 1 |
| Shin, AK | 1 |
| Donato, AA | 1 |
| Kim, DM | 3 |
| Cho, HS | 1 |
| Kang, JI | 1 |
| Kim, HS | 1 |
| Park, CY | 1 |
| Preda, TC | 1 |
| Preda, VA | 1 |
| Mekisic, AP | 1 |
| Dabanch P, J | 2 |
| Herrero C, D | 1 |
| Pavéz A, C | 1 |
| Veas P, N | 1 |
| Braun J, S | 2 |
| Porte T, L | 1 |
| Neupane, GP | 2 |
| Ulloa F, MT | 1 |
| Porte, L | 1 |
| Fica C, A | 1 |
| Henríquez A, T | 1 |
| Osorio A, CG | 1 |
| Yun, NR | 1 |
| Shin, SH | 1 |
| Lim, SC | 1 |
| Choi, CH | 1 |
| Campanelli, A | 1 |
| Sanchez-Politta, S | 1 |
| Saurat, JH | 1 |
| Chan, TY | 1 |
| Chow, DP | 1 |
| Ng, KC | 1 |
| Pang, KW | 1 |
| McBride, GA | 1 |
| Liu, PC | 1 |
| Lee, KK | 1 |
| Chen, SN | 1 |
| Meadors, MC | 1 |
| Pankey, GA | 1 |
1 review available for ciprofloxacin and Infections, Vibrio
| Article | Year |
|---|---|
[Vibrio parahaemolyticus bacteremia: case report and literature review].
Topics: Aged, 80 and over; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Humans; Male; Treatment Outcome | 2009 |
19 other studies available for ciprofloxacin and Infections, Vibrio
| Article | Year |
|---|---|
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.
Topics: Aeromonas; Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; M | 2008 |
An unusual urinary tract infection caused by Vibrio fluvialis.
Topics: Ciprofloxacin; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections; V | 2018 |
Necrotizing wound infection from a tilapia fish injury.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Fasciitis, Necrotizing; Female; Humans; | 2017 |
Efficacy of Ceftriaxone, Cefepime, Doxycycline, Ciprofloxacin, and Combination Therapy for Vibrio vulnificus Foodborne Septicemia.
Topics: Animals; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Doxycycline; D | 2017 |
Outcomes of Third-Generation Cephalosporin Plus Ciprofloxacin or Doxycycline Therapy in Patients with Vibrio vulnificus Septicemia: A Propensity Score-Matched Analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Ciprofl | 2019 |
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Colony Count, Microbial; Disease Models, | 2019 |
In vivo efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus sepsis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Cefotaxime; Cell Death; Ciprofloxacin; Colony Coun | 2014 |
[Analysis of antimicrobial resistance results of Vibrio parahaemolyticus isolated from shellfish and its habitat in 2013].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; China; Chloramphenicol; Ciprofloxacin; Drug R | 2015 |
Starch dust explosion and flame burn injury in a patient complicated with severe cellulites caused by non-O1 Vibrio cholerae.
Topics: Anti-Bacterial Agents; Burns; Cellulite; Ciprofloxacin; Dust; Explosions; Humans; Male; Microbial Se | 2016 |
Vibrio vulnificus infection and liver cirrhosis: a potentially lethal combination.
Topics: Adult; Animals; Ciprofloxacin; Debridement; Doxycycline; Early Diagnosis; Humans; Liver Cirrhosis; M | 2016 |
Deferasirox plus ciprofloxacin combination therapy after rapid diagnosis of Vibrio vulnificus sepsis using real-time polymerase chain reaction.
Topics: Aged; Anti-Bacterial Agents; Benzoates; Ciprofloxacin; Deferasirox; DNA, Bacterial; Drug Therapy, Co | 2008 |
Septic shock from penetrating leg injury with Vibrio vulnificus infection.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Diagnosis, Differential; Female; Humans; Injections, Int | 2009 |
In vitro time-kill activities of ciprofloxacin alone and in combination with the iron chelator deferasirox against Vibrio vulnificus.
Topics: Anti-Bacterial Agents; Benzoates; Chelating Agents; Ciprofloxacin; Deferasirox; Drug Synergism; Hosp | 2010 |
[Acute gastroenteritis caused by a Vibrio cholerae non-O1, non-O139 strain harboring a genetic region homologous to the VpaI-7 pathogenicity island].
Topics: Acute Disease; Anti-Infective Agents; Ciprofloxacin; Female; Gastroenteritis; Genomic Islands; Human | 2011 |
Quantitative PCR and in vivo efficacy of antibiotics in the treatment of Vibrio vulnificus infection in a mouse model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bacteriological Techniques; Blood; Ceftriaxone; Cipr | 2012 |
[Cutaneous ulceration after an octopus bite: infection due to Vibrio alginolyticus, an emerging pathogen].
Topics: Animals; Anti-Infective Agents; Bites and Stings; Ciprofloxacin; Humans; Male; Middle Aged; Octopodi | 2008 |
Vibrio vulnificus septicemia in a patient with liver cirrhosis.
Topics: Animals; Bacteremia; Brachyura; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Female; Hepat | 1994 |
Susceptibility of different isolates of Vibrio harveyi to antibiotics.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Decapoda; Doxycycline; Drug Resistan | 1997 |
Vibrio vulnificus wound infection treated successfully with oral ciprofloxacin.
Topics: Aged; Cellulitis; Ciprofloxacin; Humans; Male; Vibrio Infections; Wound Infection | 1990 |